Jorge Álvarez Troncoso (@joraltron) 's Twitter Profile
Jorge Álvarez Troncoso

@joraltron

Internal Medicine|Systemic Autoimmune Diseases
|#Sistémicas|#EAS #EAI #Myositis #Myopathy #MSGB #POCUS #AI #Rare #Immune #irAE #COVID|#USC #APHP #CTO #UAM|

ID: 712771853450878977

linkhttps://orcid.org/0000-0003-1108-9461 calendar_today23-03-2016 22:43:47

5,5K Tweet

2,2K Followers

1,1K Following

Dr.Mukesh , MD , DM (@dr_immuno29) 's Twitter Profile Photo

🚨 Findings Alert on Behcet ‘s Syndrome 🚨 🔍 Research highlights the benefits of Infliximab over Cyclophosphamide: • 🏆 Higher complete response rate: **Infliximab 81% vs. Cyclophosphamide 56%** . 🩸 Significant vascular response: **Infliximab 94% vs. 56%** for Cyclophosphamide

🚨 Findings Alert on Behcet ‘s Syndrome 🚨
🔍 Research highlights the benefits of Infliximab over Cyclophosphamide:
• 🏆 Higher complete response rate: **Infliximab 81% vs. Cyclophosphamide 56%**
. 🩸 Significant vascular response: **Infliximab 94% vs. 56%** for Cyclophosphamide
Laurent ARNAUD (@lupusreference) 's Twitter Profile Photo

✅ I think this is the first time we do a full NATION-WIDE study about #GLUCOCORTICOIDS related SIDE-EFFECTS in #LUPUS. These are pooled data from >30,000 French patients with #SLE. Unfortunately, I think the message is CLEAR 😭 Download link: lupus.bmj.com/content/lupuss…

✅ I think this is the first time we do a full NATION-WIDE study about #GLUCOCORTICOIDS related SIDE-EFFECTS in #LUPUS. These are pooled data from >30,000 French patients with #SLE. Unfortunately, I think the message is CLEAR 😭
Download link: lupus.bmj.com/content/lupuss…
The Lancet Rheumatology (@thelancetrheum) 's Twitter Profile Photo

NEW RESEARCH—Clinical manifestations, disease penetrance, and treatment in individuals with #SOCS1 (suppressor of cytokine signalling 1) insufficiency: a registry-based and population-based study bit.ly/3QKo0qx #RareDiseaseDay

NEW RESEARCH—Clinical manifestations, disease penetrance, and treatment in individuals with #SOCS1 (suppressor of cytokine signalling 1) insufficiency: a registry-based and population-based study bit.ly/3QKo0qx #RareDiseaseDay
Pankti Mehta (@panktimehta24) 's Twitter Profile Photo

Be careful of ruling out a systemic rheumatic disease based on a DFS pattern on ANA! This pattern can be confused with other patterns #rheumatology #CRA2025 CRA SCR maychoi

Be careful of ruling out a systemic rheumatic disease based on a DFS pattern on ANA! 
This pattern can be confused with other patterns 

#rheumatology #CRA2025 <a href="/CRASCRRheum/">CRA SCR</a> <a href="/maychoi_lab/">maychoi</a>
Autoinmunes Medicina Interna Parc Taulí (@autoinmi_tauli) 's Twitter Profile Photo

Treatment guidelines for idiopathic inflammatory myopathies in adults: a comparative review ⏩treatment varies widely due to limited evidence & regional differences. ⏩ differ in diagnosis & management. ⏩multidisciplinary approach can improve outcomes. academic.oup.com/rheumatology/a…

Treatment guidelines for idiopathic inflammatory myopathies in adults: a comparative review

⏩treatment varies widely due to limited evidence &amp; regional differences.
⏩ differ in diagnosis &amp; management. ⏩multidisciplinary approach can improve outcomes.

academic.oup.com/rheumatology/a…
Alberto Giraldo (@alb_giraldo) 's Twitter Profile Photo

Summary of #myositis subtypes including clinical characteristics, demographics, extra-muscular systemic manifestations and associated #autoantibodies for each subtype. *From: Paik JJ, Werth VP, Chinoy H, et al. Treatment guidelines for idiopathic inflammatory #myopathies in

Summary of #myositis subtypes including clinical characteristics, demographics, extra-muscular systemic manifestations and associated #autoantibodies for each subtype.

*From: Paik JJ, Werth VP, Chinoy H, et al. Treatment guidelines for idiopathic inflammatory #myopathies in
RMD Open (@bmj_rmdopen) 's Twitter Profile Photo

▶️ Comprehensive risk assessment for pulmonary manifestations in systemic lupus erythematosus: a large-scale Korean population-based longitudinal study 🫁🔍 New study reveals that #SLE patients have a 3.3-fold higher risk of pulmonary manifestations vs. matched controls! 🚨

ILLIASUL IBAD (@illiasulk) 's Twitter Profile Photo

Tweet 1: 🚀 The JAK-STAT Pathway – A Key Player in Cytokine Signaling! Did you know that >40 receptors use this pathway? It’s critical for immune function, hematopoiesis, and inflammation! Let’s break down JAKs, STATs, inhibitors & their clinical impact in a simple & engaging

Tweet 1:

🚀 The JAK-STAT Pathway – A Key Player in Cytokine Signaling!

Did you know that &gt;40 receptors use this pathway? It’s critical for immune function, hematopoiesis, and inflammation!

Let’s break down JAKs, STATs, inhibitors &amp; their clinical impact in a simple &amp; engaging
Medicina Interna - La Paz 🩺 (@interna_lapaz) 's Twitter Profile Photo

¡Hola futuros MIRs! Este 24 de marzo en La Paz los esperamos en “Yo Soy HULP”, una jornada de puertas abiertas donde explorarán diversas especialidades. Del mundo de opciones, queremos que sientan la pasión de la Medicina Interna. ¡Ven y déjate inspirar! #YoSoyHULP Sociedad Española de Medicina Interna (SEMI)

¡Hola futuros MIRs! Este 24 de marzo en La Paz los esperamos en “Yo Soy HULP”, una jornada de puertas abiertas donde explorarán diversas especialidades. Del mundo de opciones, queremos que sientan la pasión de la Medicina Interna. ¡Ven y déjate inspirar! #YoSoyHULP <a href="/Sociedad_SEMI/">Sociedad Española de Medicina Interna (SEMI)</a>
Alberto Giraldo (@alb_giraldo) 's Twitter Profile Photo

A comprehensive post hoc analysis of data from RESOLVE-1, the largest clinical trial conducted to date in diffuse cutaneous systemic sclerosis, shows #mycophenolate mofetil (MMF) significantly outperforms other #immunosuppressive therapies or no treatment in improving skin

A comprehensive post hoc analysis of data from
RESOLVE-1, the largest clinical trial conducted to date in diffuse cutaneous systemic sclerosis, shows #mycophenolate mofetil (MMF) significantly outperforms other #immunosuppressive therapies or no treatment in improving skin
U. M. Sistèmiques. Medicina Interna H. V. d'Hebron (@mivhsistemiques) 's Twitter Profile Photo

Ja arriba la III Jornada de la Unitat de M. Sistèmiques del Servei de Med. Interna. Quan? Dia 5 de maig. Com? Inscripció GRATUÏTA. Acreditada pel CCFCPS amb 0.9 crèdits. Format mixt presencial i online. Us hi voleu apuntar? Link: vallhebron.com/docencia/aula/…

Alberto Giraldo (@alb_giraldo) 's Twitter Profile Photo

#Hydroxyurea-induced #dermatomyositis (DM)-like eruption is a rare skin reaction characterized by scaly erythematous to violaceous papules and plaques with atrophy and telangiectasias on the dorsal hands, clinically indistinguishable from true DM. However, DM-like eruption cases

#Hydroxyurea-induced #dermatomyositis (DM)-like eruption is a rare skin reaction characterized by scaly erythematous to violaceous papules and plaques with atrophy and telangiectasias on the dorsal hands, clinically indistinguishable from true DM. However, DM-like eruption cases
Asociación Española de Sjögren (@aesjogren) 's Twitter Profile Photo

🧠 Conocer tu enfermedad es el 1er paso para cuidarte mejor. Mantener los controles médicos, seguir el tratamiento, cuidar lo que comemos y mover nuestro cuerpo a través del ejercicio físico, no es solo una rutina médica… es autocuidado, amor propio y compromiso con nuestra

Aegastro (@aegastro) 's Twitter Profile Photo

👩‍⚕️👨‍⚕️ ¿Os habéis encontrado alguna vez con una paniculitis mesentérica y no sabéis cómo actuar? ➡️ Os recomendamos esta revisión de la AGA 🤔 Cómo diagnosticarlo y cómo tratarlo (si fuera necesario)⤵️ cghjournal.org/article/S1542-…

👩‍⚕️👨‍⚕️ ¿Os habéis encontrado alguna vez con una paniculitis mesentérica y no sabéis cómo actuar?

➡️ Os recomendamos esta revisión de la AGA 

🤔 Cómo diagnosticarlo y cómo tratarlo (si fuera necesario)⤵️

cghjournal.org/article/S1542-…
Iago Pinal-Fernandez (@driagopinal) 's Twitter Profile Photo

Exploring novel therapies for idiopathic inflammatory myopathies and examining future perspectives. Current Treatment Options in Rheumatology 2025. doi.org/10.1007/s40674…